Antibacterial natural products in medicinal chemistry--exodus or revival? (Q28255204)

natural product chemistry

Europe PubMed Central

title

Antibacterial natural products in medicinal chemistry--exodus or revival? (English)

0 references

1 reference

1 reference

Franz von Nussbaum

1

0 references

Michael Brands

2

0 references

Berthold Hinzen

3

0 references

Stefan Weigand

4

0 references

Dieter Häbich

Angewandte Chemie International Edition

5

0 references

language of work or name

English

0 references

publication date

4 August 2006

0 references

published in

0 references

volume

45

0 references

issue

31

0 references

page(s)

5072-129

0 references

cites work

Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

armA and aminoglycoside resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Antimicrobial susceptibility of coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Amoxicillin-sulbactam: A clinical and therapeutic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Homage from one Sardinian to another

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Cephalosporins: a pharmacological update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Recent developments on ketolides and macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Telithromycin (HMR 3647): The first ketolide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Antibacterial activity and pharmacokinetics of clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Antibiotic and pseudomembranous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

In vitro comparison of clindamycin and pirlimycin (U-57930E) activity against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Effect of furanomycin on the synthesis of isoleucyl-tRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

CHEMICAL STUDIES ON TUBERACTINOMYCIN. III

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Chemical studies on tuberactinomycin. XV. Total synthesis of tuberactinomycin O

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Studies on viomycin. IX. Amino acid derivatives of viomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Studies on viomycin. VII. Oxidative modifications of viomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

21 January 2018

Glycopeptide derivatives

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Lysobactin, a novel antibacterial agent produced by Lysobacter sp. I. Taxonomy, isolation and partial characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Lysobactin, a novel antibacterial agent produced by Lysobacter sp. II. Biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Isolation and characterization of katanosins A and B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

Recent developments in depsipeptide research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.200600350

TAN-1057 A-D, new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Taxonomy, fermentation and biological activity.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.606

LL-AF283 antibiotics, cyclic biphenyl peptides

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.674

Biphenomycins A and B, novel peptide antibiotics. II. Structural elucidation of biphenomycins A and B

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.38.1462

Biphenomycins A and B, novel peptide antibiotics. I. Taxonomy, fermentation, isolation and characterization.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.38.1453

Olivanic acids, a family of .BETA.-lactam antibiotics with .BETA.-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.295

Studies on free radical scavenging substances from microorganisms. I. Carazostatin, a new free radical scavenger produced by Streptomyces chromofuscus DC 118

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.1879

Identifiers

DOI

10.1002/ANIE.200600350

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1003820

OpenCitations bibliographic resource ID

1003820

1 reference